These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

298 related items for PubMed ID: 34584131

  • 1. Effects of Aβ-derived peptide fragments on fibrillogenesis of Aβ.
    Abedin F, Kandel N, Tatulian SA.
    Sci Rep; 2021 Sep 28; 11(1):19262. PubMed ID: 34584131
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of beta-amyloid(40) fibrillogenesis and disassembly of beta-amyloid(40) fibrils by short beta-amyloid congeners containing N-methyl amino acids at alternate residues.
    Gordon DJ, Sciarretta KL, Meredith SC.
    Biochemistry; 2001 Jul 27; 40(28):8237-45. PubMed ID: 11444969
    [Abstract] [Full Text] [Related]

  • 3. Covalent modifier-type aggregation inhibitor of amyloid-β based on a cyclo-KLVFF motif.
    Kino R, Araya T, Arai T, Sohma Y, Kanai M.
    Bioorg Med Chem Lett; 2015 Aug 01; 25(15):2972-5. PubMed ID: 26045033
    [Abstract] [Full Text] [Related]

  • 4. Chitosan Oligosaccharides Inhibit/Disaggregate Fibrils and Attenuate Amyloid β-Mediated Neurotoxicity.
    Dai X, Hou W, Sun Y, Gao Z, Zhu S, Jiang Z.
    Int J Mol Sci; 2015 May 08; 16(5):10526-36. PubMed ID: 26006224
    [Abstract] [Full Text] [Related]

  • 5. S14G-humanin inhibits Aβ1-42 fibril formation, disaggregates preformed fibrils, and protects against Aβ-induced cytotoxicity in vitro.
    Zhang W, Du Y, Bai M, Xi Y, Li Z, Miao J.
    J Pept Sci; 2013 Mar 08; 19(3):159-65. PubMed ID: 23349038
    [Abstract] [Full Text] [Related]

  • 6. Abeta20-29 peptide blocking apoE/Abeta interaction reduces full-length Abeta42/40 fibril formation and cytotoxicity in vitro.
    Hao J, Zhang W, Zhang P, Liu R, Liu L, Lei G, Su C, Miao J, Li Z.
    Neuropeptides; 2010 Aug 08; 44(4):305-13. PubMed ID: 20363024
    [Abstract] [Full Text] [Related]

  • 7. Preparation and characterization of a highly soluble Aβ1-42 peptide variant.
    LeVatte MA, Lipfert M, Ladner-Keay C, Wishart DS.
    Protein Expr Purif; 2019 Dec 08; 164():105480. PubMed ID: 31425755
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Crocus-derived compounds alter the aggregation pathway of Alzheimer's Disease: associated beta amyloid protein.
    Koulakiotis NS, Purhonen P, Gikas E, Hebert H, Tsarbopoulos A.
    Sci Rep; 2020 Oct 23; 10(1):18150. PubMed ID: 33097779
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pyroglutamylated amyloid-β peptide reverses cross β-sheets by a prion-like mechanism.
    Matos JO, Goldblatt G, Jeon J, Chen B, Tatulian SA.
    J Phys Chem B; 2014 May 29; 118(21):5637-43. PubMed ID: 24802697
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Ferrocene tripeptide Gly-Pro-Arg conjugates: synthesis and inhibitory effects on Alzheimer's Aβ(1-42) fibrillogenesis and Aβ-induced cytotoxicity in vitro.
    Zhou B, Li CL, Hao YQ, Johnny MC, Liu YN, Li J.
    Bioorg Med Chem; 2013 Jan 15; 21(2):395-402. PubMed ID: 23245572
    [Abstract] [Full Text] [Related]

  • 18. Identification of prion protein-derived peptides of potential use in Alzheimer's disease therapy.
    Nieznanska H, Bandyszewska M, Surewicz K, Zajkowski T, Surewicz WK, Nieznanski K.
    Biochim Biophys Acta Mol Basis Dis; 2018 Jun 15; 1864(6 Pt A):2143-2153. PubMed ID: 29604335
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.